FDA Clears Magstim Transcranial Magnetic Stimulation System Horizon 3.0 with StimGuide Pro FDA clears Magstim TMS System Horizon 3.0 with StimGuide Pro providing treatment for patients patients with depressive or obsessive-compulsive conditions

Advanced FDA Cleared Magstim Horizon 3.0 Transcranial Magnetic Stimulation Now Available in United Kingdom WHITLAND, United Kingdom, July 07, 2023 (GLOBE NEWSWIRE) -- The advanced and FDA-cleared Magstim Horizon 3.0 transcranial magnetic stimulation (TMS) system is now UKCA registered and available for...

FDA Clears Magstim Transcranial Magnetic Stimulation for Obsessive Compulsive Disorder MINNEAPOLIS, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Magstim, a global leader in neuroscience research and Transcranial Magnetic Stimulation (TMS) solutions for mental health, announced today that the FDA...

Transcranial Magnetic Stimulators Market 2021, Size, Share, Revenue, Growth, Trends, Competitive Landscape, Forecast Report 2021-2028 Pune, India, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Shifting focus towards the treatment of rare diseases is a factor driving the global transcranial magnetic stimulators market says Fortune Business...